Changes of myelin basic protein in the hippocampus of an animal model of type 2 diabetes

다국어 초록 (Multilingual Abstract)

In this study, we observed chronological changes in the immunoreactivity and expression level of myelin basic protein (MBP), one of the most abundant proteins in the central nervous system, in the hippocampus of Zucker diabetic fatty (ZDF) rats and their control littermates (Zucker lean control; ZLC). In the ZLC group, body weight steadily increased with age; the body weight of the ZDF group, however, peaked at 30 weeks of age, and subsequently decreased. Based on the changes of body weight, animals were divided into the following six groups: early (12-week), middle (30-week), and chronic (52-week) diabetic groups and their controls. MBP immunoreactivity was found in the alveus, strata pyramidale, and lacunosum-moleculare of the CA1 region, strata pyramidale and radiatum of the CA3 region, and subgranular zone, polymorphic layer, and molecular layer of the dentate gyrus. MBP immunoreactivity was lowest in the hippocampus of 12-week-old rats in the ZLC group, and highest in 12-week-old rats in the ZDF group. Diabetes increased MBP levels in the 12-week-old group, while MBP immunoreactivity decreased in the 30-week-old group. In the 52-week-old ZLC and ZDF groups, MBP immunoreactivity was detected in the hippocampus, similar to the 30-week-old ZDF group. Western blot results corroborated with immunohistochemical results. These results suggested that changes in the immunoreactivity and expression of MBP in the hippocampus might be a compensatory response to aging, while the sustained levels of MBP in diabetic animals could be attributed to a loss of compensatory responses in oligodendrocytes.

참고문헌 (Reference)

1 Peterson R, "Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus" 32 (32): 16-19, 1990

2 Paxinos G, "The rat brain in stereotaxic coordinates" Elsevier Academic Press 2007

3 Tompa P, "The interplay between structure and function in intrinsically unstructured proteins" 579 (579): 3346-3354, 2005

4 Ravona-Springer R, "The association of diabetes and dementia and possible implications for nondiabetic populations" 11 (11): 1609-1617, 2011

5 Tanaka J, "The age-related degeneration of oligodendrocytes in the hippocampus of the senescence-accelerated mouse(SAM)P8 : a quantitative immunohistochemical study" 28 (28): 615-618, 2005

6 Bray GA, "The Zucker-fatty rat : a review" 36 (36): 148-153, 1977

7 Winocur G, "Studies of the effects of high fat diets on cognitive function in a rat model" 1 (1): 46-49, 2005

8 Readhead C, "Role of myelin basic protein in the formation of central nervous system myelin" 605 : 280-285, 1990

9 Torres TP, "Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats" 58 (58): 78-86, 2009

10 Hwang IK, "Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes" 33 (33): 394-400, 2008

11 Nam SM, "Proteomic approach to detect changes in hippocampal protein levels in an animal model of type 2 diabetes" 108 : 246-253, 2017

12 Povlsen JA, "Protection against myocardial ischemiareperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation" 8 (8): e64093-, 2013

13 Chua SC Jr, "Phenotypes of mouse diabetes and rat fatty due to mutations in the OB(leptin)receptor" 271 (271): 994-996, 1996

14 Macq AF, "Overexpression of the myelin basic protein RNA in the cortex of a patient with Alzheimer’s disease" 89 (89): 316-, 1989

15 Salunkhe VA, "Novel approaches to restore beta cell function in prediabetes and type 2diabetes" 61 (61): 1895-1901, 2018

16 Gil V, "Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease" 65 (65): 433-444, 2006

17 Kalaria RN, "Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease" 5 (5): 305-306, 2009

18 Carré JL, "Mutations in the rat myelin basic protein gene are associated with specific alterations in other myelin gene expression" 330 (330): 17-20, 2002

19 Maldonado-Ruiz R, "Microglia activation due to obesity programs metabolic failure leading to type two diabetes" 7 (7): e254-, 2017

20 De La Monte SM, "Metabolic derangements mediate cognitive impairment and Alzheimer's disease : role of peripheral insulinresistance diseases" 54 (54): 171-178, 2012

21 Moroz N, "Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus" 15 (15): 29-44, 2008

22 Wang B, "Leptin-and leptin receptor-deficient rodent models : relevance for human type 2diabetes" 10 (10): 131-145, 2014

23 Ahn JH, "Intravenously Infused F3.Olig2Improves Memory Deficits via Restoring Myelination in the Aged Hippocampus Following Experimental Ischemic Stroke" 25 (25): 2129-2144, 2016

24 Bamm VV, "Interaction of myelin basic protein with actin in the presence of dodecylphosphocholine micelles" 49 (49): 6903-6915, 2010

25 Boggs JM, "Interaction of lipid-bound myelin basic protein with actin filaments and calmodulin" 39 (39): 7799-7806, 2000

26 Rachana KS, "Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy" 629 : 110-115, 2016

27 Derakhshan F, "Insulin and the brain" 9 (9): 102-116, 2013

28 Benedict C, "Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer’s Disease : A State-of-the-Art Review" 12 : 215-, 2018

29 Roher AE, "Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease" 41 (41): 11080-11090, 2002

30 Kilkenny C, "Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research" 8 (8): e1000412-, 2010

31 Schiekofer S, "Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network" 25 (25): 1603-1609, 2005

32 Ábrahám H, "Impaired myelination of the human hippocampal formation in Down syndrome" 30 (30): 147-158, 2012

33 Dorsemans AC, "Impaired constitutive and regenerative neurogenesis in adult hyperglycemic zebrafish" 525 (525): 442-458, 2017

34 Yates KF, "Impact of metabolic syndrome on cognition and brain : a selected review of the literature" 32 (32): 2060-2067, 2012

35 Nam SM, "Hypothyroidism increases cyclooxygenase-2 levels and pro-inflammatory response and decreases cell proliferation and neuroblast differentiation in the hippocampus" 17 (17): 5782-5788, 2018

36 Bauduceau B, "Hypoglycaemia and dementia in diabetic patients" (36 Suppl 3) : S106-S111, 2010

37 Hussain S, "Evidence for cortical neuronal loss in male type 2 diabetic Goto-Kakizaki rats" 41 (41): 551-560, 2014

38 Muñoz MC, "Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats" 50 (50): 131-138, 2001

39 Park JH, "Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus" 59 (59): 579-589, 2016

40 Pesaresi M, "Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats" 42 (42): 135-139, 2010

41 McCrimmon RJ, "Diabetes and cognitive dysfunction" 379 (379): 2291-2299, 2012

42 Cermenati G, "Diabetes alters myelin lipid profile in rat cerebral cortex : Protective effects of dihydroprogesterone" 168 : 60-70, 2017

43 Zhang L, "Diabetes Mellitus Impairs Cognitive Function in Middle-Aged Rats and Neurological Recovery in Middle-Aged Rats After Stroke" 47 (47): 2112-2118, 2016

44 Yoo DY, "Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus" 78 (78): 957-962, 2016

45 Hill CM, "Assembly of tubulin by classic myelin basic protein isoforms and regulation by post-translational modification" 44 (44): 16672-16683, 2005

46 Schmidt RE, "Analysis of the Zucker Diabetic Fatty(ZDF)type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy" 163 (163): 21-28, 2003

47 Kawashima R, "Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats" 32 (32): 1002-1010, 2007

48 Hwang IK, "Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats" 36 (36): 824-832, 2014

49 Dhananjayan K, "Activation of Macrophages and Microglia by Interferon-ã and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?" 59 (59): 467-479, 2017